Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Advanced Biology
|
March 17, 2024
The α-1 Adrenergic Receptor Antagonist Doxazosin Attenuates Liver Fibrosis by Alleviating Sinusoidal Capillarization and Liver Angiogenesis
Ai-Yuan Xiu, Qian Ding, Chang-Peng Zhu, et al.
Pharmacology & Therapeutics
|
July 14, 2020
Novel therapeutics for portal hypertension and fibrosis in chronic liver disease
Sergi Guixé-Muntet, Chang-Peng Zhu, Wei-Fen Xie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 17, 2011
Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis
Chang-Peng Zhu, Jian Shi, Yue-Xiang Chen, et al.
Journal of Digestive Diseases
|
March 27, 2023
Depletion of Tgfbr2 in hepatocytes alleviates liver fibrosis and restores hepatic function in fibrotic mice
Shu Qing Liu, Xing Deng, Chang Peng Zhu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 1, 2025
Endothelial Tgfbr2 Deficiency Ameliorate Liver Fibrosis Through Regulating Angiocrine Signalling and Macrophage Accumulation
Ru Huang, Juan Deng, Ke-Qi Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
February 15, 2023
Sulodexide attenuates liver fibrosis in mice by restoration of differentiated liver sinusoidal endothelial cell
Ru Huang, Juan Deng, Chang-Peng Zhu, et al.
Digestive Diseases and Sciences
|
August 18, 2014
The transcription factor FOXA2 suppresses gastric tumorigenesis in vitro and in vivo
Chang-Peng Zhu, Jian Wang, Bin Shi, et al.
Carcinogenesis
|
August 22, 2014
FOXA2 suppresses the metastasis of hepatocellular carcinoma partially through matrix metalloproteinase-9 inhibition
Jian Wang, Chang-Peng Zhu, Ping-Fang Hu, et al.
Theranostics
|
May 28, 2019
Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4α
Bai-Nan Zheng, Chen-Hong Ding, Shi-Jie Chen, et al.
Gut
|
November 16, 2019
miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy
Wen-Ping Xu, Jin-Pei Liu, Ji-Feng Feng, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Advanced Biology
|
March 17, 2024
The α-1 Adrenergic Receptor Antagonist Doxazosin Attenuates Liver Fibrosis by Alleviating Sinusoidal Capillarization and Liver Angiogenesis
Ai-Yuan Xiu, Qian Ding, Chang-Peng Zhu, et al.
Pharmacology & Therapeutics
|
July 14, 2020
Novel therapeutics for portal hypertension and fibrosis in chronic liver disease
Sergi Guixé-Muntet, Chang-Peng Zhu, Wei-Fen Xie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 17, 2011
Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis
Chang-Peng Zhu, Jian Shi, Yue-Xiang Chen, et al.
Journal of Digestive Diseases
|
March 27, 2023
Depletion of Tgfbr2 in hepatocytes alleviates liver fibrosis and restores hepatic function in fibrotic mice
Shu Qing Liu, Xing Deng, Chang Peng Zhu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 1, 2025
Endothelial Tgfbr2 Deficiency Ameliorate Liver Fibrosis Through Regulating Angiocrine Signalling and Macrophage Accumulation
Ru Huang, Juan Deng, Ke-Qi Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
February 15, 2023
Sulodexide attenuates liver fibrosis in mice by restoration of differentiated liver sinusoidal endothelial cell
Ru Huang, Juan Deng, Chang-Peng Zhu, et al.
Digestive Diseases and Sciences
|
August 18, 2014
The transcription factor FOXA2 suppresses gastric tumorigenesis in vitro and in vivo
Chang-Peng Zhu, Jian Wang, Bin Shi, et al.
Carcinogenesis
|
August 22, 2014
FOXA2 suppresses the metastasis of hepatocellular carcinoma partially through matrix metalloproteinase-9 inhibition
Jian Wang, Chang-Peng Zhu, Ping-Fang Hu, et al.
Theranostics
|
May 28, 2019
Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4α
Bai-Nan Zheng, Chen-Hong Ding, Shi-Jie Chen, et al.
Gut
|
November 16, 2019
miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy
Wen-Ping Xu, Jin-Pei Liu, Ji-Feng Feng, et al.
Page
of 2